Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics forging ahead to complement traditional medical approaches and augment patient care
The development of software applications that are available with a prescription took a major step forward last year with the first FDA approval for a mobile medical application with both a safety and efficacy label.
This free pharmaphorum webinar saw our expert panel discuss:
- Growth and investment in digital health, the digital therapeutics (DTx) spectrum and where pharma is active in this space
- What is a DTx, how the digital health landscape is expanding and what are the benefits of DTx
- The value of DTx for patients, with some case studies for patients and HCPs (and pharma) and a look at the reimbursement of DTx – what to address and what counts as ‘value’
- The anatomy of a DTx, the customer experience component, and then a look at the ‘go-to-market’ part of these solutions
Roberto Ascione, Healthware CEO, has joined the expert panel along with Megan Coder, Executive Director at Digital Therapeutics Alliance, Pierre Leurent, CEO and founder at Voluntis, Marc Sluijs, Founder at DigitalHealth.Network and Dominic Tyer, Creative Director at pharmaphorum and moderator of the panel.